Search Results

Cannabinoid signalling in the enteric nervous system

Author: galligan, j. j.

Source: Neurogastroenterology and Motility, Volume 21, Number 9, September 2009 , pp. 899-902(4)

Publisher: Blackwell Publishing

Editorial [Hot topic: Endocannabinoid Signaling and Neuroinflammatory Diseases (Executive Editor: Mauro Maccarrone)]

Author: Maccarrone, Mauro

Source: Current Pharmaceutical Design, Volume 14, Number 23, August 2008 , pp. 2252-2253(2)

Publisher: Bentham Science Publishers

Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats

Authors: Roche, Michelle; Kelly, John P.; O'Driscoll, Maeve; Finn, David P.

Source: Immunology, Volume 125, Number 2, October 2008 , pp. 263-271(9)

Publisher: Blackwell Publishing

Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats

Authors: Resstel, L.; Lisboa, S.; Aguiar, D.; Corrêa, F.; Guimarães, F.

Source: Psychopharmacology, Volume 198, Number 3, June 2008 , pp. 405-411(7)

Publisher: Springer

ACTIONS OF THE ENDOCANNABINOID TRANSPORT INHIBITOR AM404 IN NEUROPATHIC AND INFLAMMATORY PAIN MODELS

Authors: Mitchell, Vanessa A; Greenwood, Ruth; Jayamanne, Angelo; Vaughan, Christopher W

Source: Clinical and Experimental Pharmacology and Physiology, Volume 34, Number 11, November 2007 , pp. 1186-1190(5)

Publisher: Blackwell Publishing

Modulation of the Endocannabinoid System by Lipid Rafts

Authors: Dainese, Enrico; Oddi, Sergio; Bari, Monica; Maccarrone, Mauro

Source: Current Medicinal Chemistry, Volume 14, Number 25, October 2007 , pp. 2702-2715(14)

Publisher: Bentham Science Publishers

The anandamide transport inhibitor AM404 reduces ethanol self-administration

Authors: Cippitelli, Andrea; Bilbao, Ainhoa; Gorriti, Miguel Angel; Navarro, Miguel; Massi, Maurizio; Piomelli, Daniele; Ciccocioppo, Roberto; de Fonseca, Fernando Rodríguez

Source: European Journal of Neuroscience, Volume 26, Number 2, July 2007 , pp. 476-486(11)

Publisher: Blackwell Publishing

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake

Authors: Gasperi, V.; Fezza, F.; Pasquariello, N.; Bari, M.; Oddi, S.; Agrò, A.; Maccarrone, M.

Source: Cellular and Molecular Life Sciences CMLS, Volume 64, Number 2, January 2007 , pp. 219-229(11)

Publisher: Springer

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward

Authors: Vlachou, Styliani; Nomikos, George; Panagis, George

Source: Psychopharmacology, Volume 188, Number 3, October 2006 , pp. 293-305(13)

Publisher: Springer

Pharmacological Characterization of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Inhibitors

Authors: Dickason-Chesterfield, Amy; Kidd, Stephanie; Moore, Steven; Schaus, John; Liu, Bin; Nomikos, George; Felder, Christian

Source: Cellular and Molecular Neurobiology, Volume 26, Numbers 4-6, July 2006 , pp. 405-421(17)

Publisher: Springer

Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB₁ receptors

Authors: Millns, P. J.; Chimenti, M.; Ali, N.; Ryland, E.; de Lago, E.; Fernandez-Ruiz, J.; Chapman, V.; Kendall, D. A.

Source: European Journal of Neuroscience, Volume 24, Number 12, December 2006 , pp. 3489-3495(7)

Publisher: Blackwell Publishing

N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a

Authors: Wiles, Amy L.; Pearlman, Rhonda-Jo; Rosvall, Mari; Aubrey, Karin R.; Vandenberg, Robert J.

Source: Journal of Neurochemistry, Volume 99, Number 3, November 2006 , pp. 781-786(6)

Publisher: Blackwell Publishing

The Endocannabinoid System in Ageing: A New Target for Drug Development

Authors: Paradisi, A.; Oddi, S.; Maccarrone

Source: Current Drug Targets, Volume 7, Number 11, November 2006 , pp. 1539-1552(14)

Publisher: Bentham Science Publishers

Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)

Authors: Piomelli, Daniele; Tarzia, Giorgio; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Compton, Timothy R.; Dasse, Olivier; Monaghan, Edward P.; Parrott, Jeff A.; Putman, David

Source: CNS Drug Reviews, Volume 12, Number 1, March 2006 , pp. 21-38(18)

Publisher: Blackwell Publishing

Cannabinoid Drugs and Enhancement of Endocannabinoid Responses: Strategies for a Wide Array of Disease States

Authors: Karanian, David A.; Bahr, Ben A.

Source: Current Molecular Medicine, Volume 6, Number 6, September 2006 , pp. 677-684(8)

Publisher: Bentham Science Publishers

Targeting the endocannabinoid system in treating brain disorders

Authors: Bahr, Ben A; Karanian, David A; Makanji, Sagar S; Makriyannis, Alexandros

Source: Expert Opinion on Investigational Drugs, Volume 15, Number 4, 1 April 2006 , pp. 351-365(15)

Publisher: Informa Healthcare

New Insights into Endocannabinoid Degradation and its Therapeutic Potential

Authors: Bari, M.; Battista, N.; Fezza, F.; Gasperi, V.; Maccarrone, M.

Source: Mini Reviews in Medicinal Chemistry, Volume 6, Number 3, March 2006 , pp. 257-268(12)

Publisher: Bentham Science Publishers

The anandamide membrane transporter and the therapeutic implications of its inhibition

Authors: Battista, Natalia; Gasperi, Valeria; Fezza, Filomena; Maccarrone, Mauro

Source: Therapy, Volume 2, Number 1, January 2005 , pp. 141-150(10)

Publisher: Future Medicine

Synthesis of a photoactivatable probe of the anandamide re-uptake

Authors: Balas, Laurence; Hellal, Malik; Rossi, Jean-Claude; Durand, Thierry

Source: Natural Product Research, Volume 19, Number 4, June 2005 , pp. 419-423(5)

Publisher: Taylor and Francis Ltd

Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat

Authors: Jennifer Ronesi; David M. Lovinger

Source: The Journal of Physiology, Volume 562, Number 1, January 2005 , pp. 245-256(12)

Publisher: Blackwell Publishing